| EP1613296 - METHODS FOR TREATMENT OF PARKINSON'S DISEASE [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 07.05.2010 Database last updated on 07.04.2026 | Most recent event Tooltip | 07.05.2010 | No opposition filed within time limit | published on 09.06.2010 [2010/23] | Applicant(s) | For all designated states Newron Pharmaceuticals S.p.A. Via L. Ariosto, 21 20091 Bresso (MI) / IT | [2006/02] | Inventor(s) | 01 /
RUGGERO, Fariello Via della Vittoria, 22 I-21016 Luino / IT | 02 /
CATTANEO, Carlo Via C. Armellini, 31 I-20161 Milano / IT | 03 /
SALVATI, Patricia Via Valera, 16/c I-20020 Arese / IT | 04 /
BENATTI, Luca Via della Repubblica, 43 I-20093 S. Maurizio al Lambro / IT | [2006/02] | Representative(s) | Minoja, Fabrizio Bianchetti & Minoja S.r.l. Via Plinio, 63 20129 Milano / IT | [N/P] |
| Former [2006/02] | Minoja, Fabrizio Bianchetti Bracco Minoja S.r.l. Via Plinio, 63 20129 Milano / IT | Application number, filing date | 04726590.5 | 08.04.2004 | [2006/02] | WO2004IB01408 | Priority number, date | US20030462205P | 11.04.2003 Original published format: US 462205 P | [2006/02] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2004089353 | Date: | 21.10.2004 | Language: | EN | [2004/43] | Type: | A2 Application without search report | No.: | EP1613296 | Date: | 11.01.2006 | Language: | EN | The application published by WIPO in one of the EPO official languages on 21.10.2004 takes the place of the publication of the European patent application. | [2006/02] | Type: | B1 Patent specification | No.: | EP1613296 | Date: | 01.07.2009 | Language: | EN | [2009/27] | Search report(s) | International search report - published on: | EP | 16.12.2004 | Classification | IPC: | A61K31/16, A61P25/16 | [2006/02] | CPC: |
A61K31/165 (EP,US);
A61K31/16 (EP,KR,US);
A61K31/137 (EP,US);
A61K31/473 (EP,US);
A61K31/4745 (EP,US);
A61K31/475 (EP,US);
A61K31/48 (EP,US);
A61K31/485 (EP,US);
A61K31/498 (EP,US);
A61K31/4985 (EP,US);
A61K31/55 (EP,US);
A61K45/06 (EP,US);
| C-Set: |
A61K31/137, A61K2300/00 (US,EP);
A61K31/16, A61K2300/00 (EP,US);
A61K31/473, A61K2300/00 (US,EP);
A61K31/48, A61K2300/00 (US,EP); | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/02] | Extension states | AL | Not yet paid | HR | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | Title | German: | VERFAHREN ZUR BEHANDLUNG VON PARKINSON-KRANKHEIT | [2006/02] | English: | METHODS FOR TREATMENT OF PARKINSON'S DISEASE | [2006/02] | French: | PROCEDES DE TRAITEMENT DE LA MALADIE DE PARKINSON | [2006/02] | Entry into regional phase | 04.10.2005 | National basic fee paid | 04.10.2005 | Designation fee(s) paid | 04.10.2005 | Examination fee paid | Examination procedure | 04.10.2005 | Amendment by applicant (claims and/or description) | 04.10.2005 | Examination requested [2006/02] | 16.12.2005 | Despatch of a communication from the examining division (Time limit: M08) | 09.08.2006 | Reply to a communication from the examining division | 05.12.2006 | Despatch of a communication from the examining division (Time limit: M04) | 06.04.2007 | Reply to a communication from the examining division | 19.11.2007 | Date of oral proceedings | 25.01.2008 | Communication of intention to grant the patent | 25.01.2008 | Minutes of oral proceedings despatched | 14.05.2008 | Fee for grant paid | 14.05.2008 | Fee for publishing/printing paid | Divisional application(s) | EP09154864.4 / EP2070526 | Opposition(s) | 06.04.2010 | No opposition filed within time limit [2010/23] | Fees paid | Renewal fee | 24.04.2006 | Renewal fee patent year 03 | 25.04.2007 | Renewal fee patent year 04 | 24.04.2008 | Renewal fee patent year 05 | 24.04.2009 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X] ANONYMOUS: "Newron Releases Positive Preliminary Phase II Data for Salfinamide in Parkinson's Disease", PRESS RELEASE OF 03.01.03, XP002290820, Retrieved from the Internet | Examination | STOCCHI ET AL: "SYMPTOM RELIEF IN PARKINSON DISEASE BY SAFINAMIDE", NEUROLOGY, vol. 67, no. SUPPL1, 2006 - 2006, pages S24 - S29, XP009073546 * figure 3 * |